Washington University School of Medicine scientists used an antibody to block CXCR3, limiting T cells entering the brains of mice with Alzheimer’s-like tau buildup. After months of treatment, brain T cells fell by about half; mice kept roughly 40% more tissue in memory regions and did better on memo